LOINCActiveBoth

LOINC Code 100972-9: Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+non-probe (Nose)

100972-9 is a LOINC code used to identify Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+non-probe (Nose) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel. It is commonly used with the system or sample type Nose.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel. It is commonly used with the system or sample type Nose.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Panel type: Panel
  • Method: Non-probe.amp.tar

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection
  • Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel
  • 2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUABV + SARS-CoV-2; FLUABV+SARS-CoV-2 RNA Pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; II; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+n-prb; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RNA Pnl; SDA; Severe Acute Respiratory Syndrome; Smell; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+non-probe (Nose)Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detectionFLUABV+SARS-CoV2 RNA Pnl Nose NAA+nonprbInfluenza virus A & Influenza virus B & SARS coronavirus 2 RNA panelPANEL.MICROInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, Nose-

Frequently asked questions

Code details

Code100972-9
SystemLOINC
Display nameInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+non-probe (Nose)
DescriptionInfluenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel
Short nameFLUABV+SARS-CoV2 RNA Pnl Nose NAA+nonprb
ComponentInfluenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel
Property-
TimingPt
System (specimen)Nose
Scale-
MethodNon-probe.amp.tar
ClassPANEL.MICRO
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.74
Last changed2.75

Consumer names

Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, Nose

Part names

Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel-PtNoseNon-probe.amp.tarInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panelPoint in time (spot)Nucleic acid amplification with non-probe detection

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.